TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Jucker Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
140
|
131
|
283 |
Financial expenses |
62
|
18
|
28 |
Earnings before taxes |
-79
|
5
|
80 |
EBITDA |
-32
|
14
|
101 |
Total assets |
578
|
402
|
468 |
Current assets |
574
|
398
|
464 |
Current liabilities |
461
|
206
|
259 |
Equity capital |
117
|
196
|
209 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
2
|
3
|
4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
20.2%
|
48.8%
|
44.7% |
Turnover per employee |
70
|
44
|
71 |
Profit as a percentage of turnover |
-56.4%
|
3.8%
|
28.3% |
Return on assets (ROA) |
-2.9%
|
5.7%
|
23.1% |
Current ratio |
124.5%
|
193.2%
|
179.2% |
Return on equity (ROE) |
-67.5%
|
2.6%
|
38.3% |
Change turnover |
8
|
-129
|
-17 |
Change turnover % |
6%
|
-50%
|
-6% |
Chg. No. of employees |
-1
![]() |
-1
|
0 |
Chg. No. of employees % |
-33%
|
-25%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.